| Line Item | 2023-01-01 | Y/Y |
|---|---|---|
| Revenue | $6.2M | — |
| Cost of Revenue | $23.2M | +1081.4% |
| Gross Profit | -$17.0M | -766.1% |
| R&D Expense | $58.1M | +53.4% |
| SG&A Expense | $52.0M | +75.0% |
| Operating Income | -$132.0M | -89.8% |
| Pre-tax Income | -$51.6M | +59.0% |
| Income Tax | $0 | — |
| Net Income | -$51.6M |
| Line Item | 2023-01-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $322.9M | -16.2% |
| Accounts Receivable | $170K | — |
| Inventory | $634K | — |
| Current Assets | $329.6M | -17.2% |
| Total Assets | $440.6M | -8.7% |
| Current Liabilities | $23.0M | +11.6% |
| Total Liabilities | $84.2M | -46.2% |
| Line Item | 2023-01-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.7M | -61.3% |
| Capital Expenditures | $36.2M | -16.9% |
| Investing Cash Flow | -$36.2M | +16.9% |
| Financing Cash Flow | $56.5M | -87.5% |
| Free Cash Flow | -$119.0M | -25.4% |
| +59.0% |
| EPS (Basic) | -$0.34 | +68.2% |
| EPS (Diluted) | -$0.82 | +23.4% |
| Stockholders' Equity |
| $356.4M |
| +9.3% |